Hemafer-S

Hemafer-S is an intravenous iron supplement containing elemental iron as its active ingredient. It is supplied as a sterile solution for intravenous administration and is prescribed in the European Union for the treatment of iron deficiency anemia. As a prescription‑only product, Hemafer‑S provides iron directly to the bloodstream to support hemoglobin synthesis and replenish depleted iron stores.

Hemafer‑S is indicated for patients who require rapid correction of iron deficiency anemia, particularly when oral iron therapy is ineffective or not tolerated. It is commonly used in clinical settings such as hospitals and infusion centers.

- Treatment of iron deficiency anemia in adults - Management of anemia associated with chronic kidney disease - Support for patients undergoing major surgery or chemotherapy - Rapid repletion of iron stores before elective procedures - Use in patients with malabsorption syndromes where oral iron is inadequate

Side effects of Hemafer‑S may vary in frequency and severity. Patients should be monitored for any adverse reactions during and after infusion.

Common: - Transient headache - Nausea or vomiting - Mild infusion site reactions (e.g., erythema, warmth) - Dizziness or light‑headedness - Low‑grade fever - Muscle cramps

Serious: - Anaphylactic or severe hypersensitivity reactions - Hypotension or cardiovascular collapse - Acute respiratory distress - Severe hypertension - Cardiac arrhythmias

Before initiating Hemafer‑S therapy, clinicians should assess patient history and current health status. The following precautions are recommended:

- Verify iron deficiency through laboratory testing before administration - Use caution in patients with a history of allergic reactions to intravenous iron products - Monitor vital signs during infusion, especially in patients with cardiovascular disease - Adjust infusion rate if hypotension or hypertension occurs - Avoid use in patients with active infections until resolved - Consider renal and hepatic function when determining suitability - Ensure appropriate resuscitation equipment is available during infusion

Hemafer‑S may interact with other medications or substances. Awareness of potential interactions can help minimize risks.

Avoid: - Concurrent administration of other intravenous iron formulations - Use with high‑dose vitamin C or ascorbic acid supplements during infusion, which may increase free iron levels

Use with caution: - Anticoagulants or antiplatelet agents (may increase bleeding risk) - Antibiotics such as quinolones (potential for reduced efficacy) - Calcium‑containing solutions (may affect iron absorption) - Medications that cause hypotension (e.g., antihypertensives) - Immunosuppressive agents (monitor for infection risk)